Amendment116th Congress
An amendment numbered 5 printed in House Report 116-61 to Commission a study by the National Academy of Medicine into the amount of federal funding and research used in the development of drugs by pharmaceutical companies, and to put measures in place to curb excessive drug costs.
- Amendment Number
- 224
- Description
- An amendment numbered 5 printed in House Report 116-61 to Commission a study by the National Academy of Medicine into the amount of federal funding and research used in the development of drugs by pharmaceutical companies, and to put measures in place to curb excessive drug costs.
- Purpose
- An amendment numbered 5 printed in House Report 116-61 to Commission a study by the National Academy of Medicine into the amount of federal funding and research used in the development of drugs by pharmaceutical companies, and to put measures in place to curb excessive drug costs.
- Congress
- 116
- Type
- HAMDT
- Latest Action Date
- May 16, 2019
- Latest Action Text
- On agreeing to the DeSaulnier amendment (A005) Agreed to by voice vote.
- Latest Action Time
- 15:21:54
- Submitted Date
- May 16, 2019
- Chamber
- House of Representatives
- Update Date
- Feb 8, 2022